Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma
Timothy P. DiPeri, Ming Zhao, Kurt W. Evans, Kaushik Varadarajan, Tyler Moss, Stephen Scott, Michael Kahle, Charnel C. Byrnes, Huiqin Chen, Sunyoung S. Lee, Abdel‐Baset Halim, Hiroshi Hirai, Volker Wacheck, Lawrence N. Kwong, Jordi Rodón, Milind Javle, Funda Meric‐Bernstam
Topics & Concepts
KRASNeuroblastoma RAS viral oncogene homologMAPK/ERK pathwayCancer researchMedicineV600EKinaseBiologyMutationInternal medicineColorectal cancerCancerGeneGeneticsFibroblast Growth Factor ResearchIgG4-Related and Inflammatory DiseasesCholangiocarcinoma and Gallbladder Cancer Studies